老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bone Biologics Corp

0.5400
-0.0001-0.02%
盤後：0.56300.0230+4.26%19:25 EDT
成交量：10.38萬
成交額：5.57萬
市值：148.83萬
市盈率：-0.34
高：0.5798
開：0.5320
低：0.5101
收：0.5401
52周最高：2.89
52周最低：0.5101
股本：275.61萬
流通股本：275.54萬
量比：3.99
換手率：3.77%
股息：- -
股息率：- -
每股收益(TTM):-1.6080
每股收益(LYR):-2.6500
淨資產收益率：-54.96%
總資產收益率：-33.46%
市淨率：0.38
市盈率(LYR):-0.20

資料載入中...

總覽公司新聞資訊公告
2021/04/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/01/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/01/09

重要事件披露

8-K - Current report
2019/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/09/25

重要事件披露

8-K - Current report
2019/08/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/08/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/07/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/06/28

重要事件披露

8-K - Current report
2019/06/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/05/24

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/04/16

重要事件披露

8-K - Current report
2019/03/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2019/03/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/03/25

重要事件披露

8-K - Current report
2018/11/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2018/09/14

重要事件披露

8-K - Current report
2018/08/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
更多